Globenewswire·2025-10-24 16:11Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and undisclosed adverse facts regarding their business operations and prospects [1]. Group 1: Marex Group plc (NASDAQ: MRX) - The class period for Marex Group is from May 16, 2024, to August 5, 2025, with a lead plaintiff deadline of December 8, 2025 [2]. - Allegations include that the company sold over-the-counter financial instruments to itself and had inconsistencies in financial statements between subsidiaries and related parties, leading to unreliable financial statements [2]. - Defendants' positive statements about the company's business were deemed materially misleading due to these undisclosed facts [2]. Group 2: aTyr Pharma Inc. (NASDAQ: ATYR) - The class period for aTyr Pharma is from January 16, 2025, to September 12, 2025, with a lead plaintiff deadline of December 8, 2025 [3]. - The complaint alleges that defendants misrepresented the study design for EFZO-FIT, creating a false impression that the drug would meet its primary endpoint [3]. - Positive statements regarding the company's business were considered materially misleading as the Phase 3 study did not meet its primary endpoint [3]. Group 3: WPP plc (NYSE: WPP) - The class period for WPP is from February 27, 2025, to July 8, 2025, with a lead plaintiff deadline of December 8, 2025 [4]. - Allegations state that WPP's media arm was not equipped to handle macroeconomic challenges and was losing market share to competitors [4]. - Defendants' positive statements about the company's business operations were found to be materially misleading due to these undisclosed challenges [4].